An update on head and neck squamous cell carcinoma in respect to classification and systemic therapy. Extended review
Head and neck squamous cell carcinoma (HNSCC) is among the 10 most common cancers and demonstrates high mortality rates. Well known for its relation to smoking and alcohol consumption, in within the past 10 years a high number of cases, especially of the oropharynx could be shown to be based on an...
Saved in:
| Main Authors: | A. Mudunov, A. Ahundov, M. Bolotin, T. Braunschweig |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2018-04-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/323 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The burden and clinical trajectory of immune checkpoint inhibitor-induced endocrinopathies: an 8-year experience
by: Fateen Ata, et al.
Published: (2024-12-01) -
Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
by: K. V. Menshikov, et al.
Published: (2022-10-01) -
NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: A. M. Mudunov, et al.
Published: (2017-06-01) -
MODERN POSSIBILITIES OF THERAPY WITH INHIBITORS OF CONTROL POINTS IN METASTATIC UROTHELIAL CANCER
by: R. A. Gafanov, et al.
Published: (2018-03-01) -
Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitro
by: Ilaria Cosci, et al.
Published: (2025-03-01)